Eric Fry just released the names of 3 AI-driven stocks he believes every investor should own, even in these crazy markets — one stock is up over 100% since the beginning of 2023.

Click here to learn their names – FOR FREE.

SPRY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 35.60%

Insider Buying (Last 12 Months): $23,301,480.00

Insider Selling (Last 12 Months): $2,276,913.11

ARS Pharmaceuticals Insider Trading History Chart

ARS Pharmaceuticals Share Price & Price History

^$3.58

▼ -0.09 (-2.45%)

As of 09/22/2023 12:15 PM ET

Days: 30 | 90 | 365

No Matter The Market, Options Trading Could Earn You More

From Tradewins | Ad

There’s no way to predict Wall Street’s future, but by using options trading, you have the opportunity to take advantage of any trend. Expert Wendy Kirkland explains how in her latest free guide.

Download it for free here!

ARS Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/1/2023	Laura Shawver	Director	Sell	100,000	$7.71	$771,000.00	210,346
8/29/2023	Ra Capital Management, L.P.	Director	Buy	3,750,000	$6.20	$23,250,000.00	5,856,774
8/4/2023	Laura Shawver	Director	Sell	18,897	$7.06	$133,412.82	210,346
8/2/2023	Laura Shawver	Director	Sell	36,281	$7.09	$257,232.29	210,346
7/6/2023	Laura Shawver	Director	Sell	33,510	$6.34	$212,453.40	210,346
7/3/2023	Laura Shawver	Director	Sell	26,520	$6.72	$178,214.40	210,346
6/1/2023	Laura Shawver	Director	Sell	73,059	$6.80	$496,801.20	210,346
5/9/2023	Laura Shawver	Director	Sell	42,900	$5.31	$227,799.00	210,346
11/29/2022	Kathleen D Scott	CFO	Buy	8,250	$6.24	$51,480.00	8,250

The single greatest medical breakthrough of all time?

From Behind the Markets | Ad

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

Get all the details here >>>

SEC Filings (Institutional Ownership Changes) for ARS Pharmaceuticals (NASDAQ:SPRY)

57.41% of ARS Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ARS Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/21/2023	Barclays PLC	20,460	$0.14M	0.0%	N/A	0.021%
8/21/2023	California State Teachers Retirement System	41,282	$0.28M	0.0%	N/A	0.043%
8/16/2023	Nuveen Asset Management LLC	97,595	$0.65M	0.0%	N/A	0.102%
8/15/2023	Alliancebernstein L.P.	24,780	$0.17M	0.0%	N/A	0.026%
8/15/2023	Wells Fargo & Company MN	9,510	$64K	0.0%	N/A	0.010%
8/15/2023	Clearline Capital LP	61,102	$0.41M	0.0%	N/A	0.064%
8/15/2023	Woodline Partners LP	670,087	$4.49M	0.1%	+11.7%	0.701%
8/15/2023	Goldman Sachs Group Inc.	123,153	$0.83M	0.0%	N/A	0.129%
8/15/2023	Stifel Financial Corp	12,327	$83K	0.0%	N/A	0.013%
8/14/2023	Tower Research Capital LLC TRC	9,503	$64K	0.0%	N/A	0.010%
8/14/2023	Marshall Wace LLP	74,621	$0.50M	0.0%	+89.3%	0.078%
8/14/2023	State of Wisconsin Investment Board	32,984	$0.22M	0.0%	N/A	0.035%
8/14/2023	State Street Corp	438,551	$2.94M	0.0%	+239.5%	0.459%
8/14/2023	Caption Management LLC	73,400	$0.49M	0.0%	N/A	0.077%
8/14/2023	Jefferies Financial Group Inc.	60,190	$0.40M	0.0%	N/A	0.063%
8/14/2023	Nuveen Asset Management LLC	97,595	$0.65M	0.0%	N/A	0.102%
8/11/2023	Renaissance Technologies LLC	304,300	$2.04M	0.0%	N/A	0.321%
8/11/2023	Credit Suisse AG	31,894	$0.21M	0.0%	N/A	0.034%
8/11/2023	BlackRock Inc.	2,260,920	$15.15M	0.0%	N/A	2.386%
8/11/2023	Sectoral Asset Management Inc.	1,255,640	$8.41M	1.4%	N/A	1.325%
8/11/2023	Rubric Capital Management LP	2,799,203	$18.76M	0.8%	-19.6%	2.954%
8/11/2023	Geode Capital Management LLC	653,595	$4.38M	0.0%	+61.9%	0.690%
8/11/2023	Tejara Capital Ltd	133,521	$0.90M	0.4%	N/A	0.141%
8/11/2023	JPMorgan Chase & Co.	22,534	$0.15M	0.0%	+671.2%	0.024%
8/11/2023	Northern Trust Corp	230,691	$1.55M	0.0%	+220.5%	0.243%
8/10/2023	MetLife Investment Management LLC	13,784	$92K	0.0%	N/A	0.015%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	16,280	$0.11M	0.0%	N/A	0.017%
8/10/2023	Nicholas Investment Partners LP	275,000	$1.84M	0.1%	N/A	0.290%
8/10/2023	Charles Schwab Investment Management Inc.	71,611	$0.48M	0.0%	N/A	0.076%
8/10/2023	Citigroup Inc.	19,972	$0.13M	0.0%	N/A	0.021%
8/9/2023	Dimensional Fund Advisors LP	393,650	$2.64M	0.0%	N/A	0.415%
8/9/2023	Swiss National Bank	82,300	$0.55M	0.0%	N/A	0.087%
8/8/2023	FAS Wealth Partners Inc.	34,250	$0.23M	0.0%	N/A	0.036%
8/7/2023	Royce & Associates LP	463,700	$3.11M	0.0%	+52.6%	0.489%
8/4/2023	American International Group Inc.	11,672	$78K	0.0%	N/A	0.012%
8/3/2023	Barclays PLC	20,460	$0.14M	0.0%	N/A	0.022%
8/3/2023	Bank of New York Mellon Corp	76,900	$0.52M	0.0%	N/A	0.081%
8/1/2023	Arizona State Retirement System	10,606	$71K	0.0%	N/A	0.011%
7/31/2023	Levin Capital Strategies L.P.	169,074	$1.13M	0.1%	N/A	0.178%
7/28/2023	Shell Asset Management Co.	65,322	$0.44M	0.0%	N/A	0.069%
7/26/2023	Janney Montgomery Scott LLC	39,969	$0.27M	0.0%	N/A	0.042%
7/25/2023	DekaBank Deutsche Girozentrale	35,000	$0.23M	0.0%	N/A	0.037%
7/24/2023	Vontobel Holding Ltd.	344,029	$2.31M	0.0%	N/A	0.363%
7/19/2023	Teacher Retirement System of Texas	10,244	$69K	0.0%	N/A	0.011%
7/18/2023	Avantax Planning Partners Inc.	32,174	$0.22M	0.0%	N/A	0.034%
6/1/2023	Prelude Capital Management LLC	15,053	$98K	0.0%	N/A	0.016%
5/23/2023	Royce & Associates LP	303,900	$1.98M	0.0%	N/A	0.321%
5/22/2023	Ameriprise Financial Inc.	280,329	$1.83M	0.0%	N/A	0.296%
5/19/2023	SR One Capital Management LP	4,012,903	$26.12M	8.9%	N/A	4.234%
5/16/2023	Jane Street Group LLC	137,450	$0.90M	0.0%	N/A	0.145%
5/16/2023	State Street Corp	129,191	$0.84M	0.0%	+50.4%	0.137%
5/16/2023	Squarepoint Ops LLC	12,903	$84K	0.0%	N/A	0.014%
5/16/2023	Geode Capital Management LLC	403,604	$2.63M	0.0%	N/A	0.427%
5/16/2023	Baker BROS. Advisors LP	2,006,451	$13.06M	0.1%	N/A	2.121%

Data available starting January 2016

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis. The company was founded in 2015 and is based in San Diego, California.

Today's Range

Now: $3.58

$3.47

$3.68

50 Day Range

MA: $6.92

$2.92

$7.48

52 Week Range

Now: $3.58

$2.55

$9.65

Volume

1,450,698 shs

Average Volume

995,895 shs

Market Capitalization

$342.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ARS Pharmaceuticals?: ARS Pharmaceuticals' top insider shareholders include:
Ra Capital Management, LP (Director)
Laura Shawver (Director)
Kathleen D Scott (CFO)
Learn More about top insider investors at ARS Pharmaceuticals.
Who are the major institutional investors of ARS Pharmaceuticals?: ARS Pharmaceuticals' top institutional shareholders include:
Rubric Capital Management LP — 2.95%
BlackRock Inc. — 2.39%
Sectoral Asset Management Inc. — 1.32%
Woodline Partners LP — 0.70%
Geode Capital Management LLC — 0.69%
Royce & Associates LP — 0.49%
Learn More about top institutional investors of ARS Pharmaceuticals stock.
Which major investors are selling ARS Pharmaceuticals stock?: In the last quarter, SPRY stock was sold by these institutional investors:
Rubric Capital Management LP
Which major investors are buying ARS Pharmaceuticals stock?: During the last quarter, SPRY stock was acquired by institutional investors including:
BlackRock Inc.
Sectoral Asset Management Inc.
Dimensional Fund Advisors LP
Vontobel Holding Ltd.
State Street Corp
Renaissance Technologies LLC
Nicholas Investment Partners LP
K2 Principal Fund L.P.
During the last year, these company insiders have bought ARS Pharmaceuticals stock:
Ra Capital Management, LP (Director)
Laura Shawver (Director)
Learn More investors buying ARS Pharmaceuticals stock.

3 AI Stocks Set to Soar in 2023

From Investorplace Media | Ad

>>>